Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Commercial
  • Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels
  • Commercial

Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels

Drug Channels

Today's guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Direct at GoodRx.

CommercialRead full story

pharminent April 24, 2026 (Last updated: April 24, 2026)

Drug Channels

Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Direct at GoodRx.

CommercialRead full story

Post navigation

Previous: OZMOSI and Planview partner to enhance pharmaceutical data integration
Next: Avalyn seeks public debut to support new lung drug formulations

Related Stories

  • Commercial

Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1

pharminent August 5, 2026
  • Commercial

Leqembi sales grow again after subcutaneous approvals

pharminent July 29, 2026
  • Commercial

Wegovy pill launches in UK as first daily oral GLP1 for weight management

pharminent July 6, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.